To study effect of ayurvedic tablet in tuberculosis along with anti kochs treatment

Efficacy of jayanti ashwagandha vatti as adjuvent therapy with antikochs treatment in pulmonary tuberculosis - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075849

Enrollment

Registered

2024-10-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A150- Tuberculosis of lung

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with sputum positive for pulmonary tuberculosis, sputum negative, chest xray positive, Drug sensitive TB patients

Exclusion criteria

Exclusion criteria: extra pulmonary tb, MDR tb, pregnant women and child patients, psychologically disturbed patients, Drug resistance tb patients, patient having hepatotoxicicty, ototoxicity, other complications

Design outcomes

Primary

Measure	Time frame
Temperature, Pain, Diarrhoea, Cough, weight gain, Haemoptysis, loss of appetiteTimepoint: 0th, 30th, 60th, 120th, 150th, 180th day	—

Secondary

Measure	Time frame
Sputum for AFB, CXR when required, USG when requiredTimepoint: 0th, 30th, 60th, 120th, 150th, 180th day	—

Countries

India

Contacts

Public ContactDr Anupama jitendra shimpi

Tilak Ayurved Mahavidyalaya and seth tarachand ramnath charitable ayurved hospital

dranupamashimpi72@gmail.com7387480800

Outcome results